150 related articles for article (PubMed ID: 19802419)
21. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
22. Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand.
Phowthongkum P; Prasanthai V; Udomsantisook N; Suankratay C
J Med Assoc Thai; 2005 Aug; 88(8):1153-62. PubMed ID: 16404850
[TBL] [Abstract][Full Text] [Related]
23. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
24. Infection of the subcutis and skin of cats with rapidly growing mycobacteria: a review of microbiological and clinical findings.
Malik R; Wigney DI; Dawson D; Martin P; Hunt GB; Love DN
J Feline Med Surg; 2000 Mar; 2(1):35-48. PubMed ID: 11716590
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
[TBL] [Abstract][Full Text] [Related]
26. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
Miyasaka T; Kunishima H; Komatsu M; Tamai K; Mitsutake K; Kanemitsu K; Ohisa Y; Yanagisawa H; Kaku M
Int J Antimicrob Agents; 2007 Sep; 30(3):255-8. PubMed ID: 17616451
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
29. Detection of lfrA and tap efflux pump genes among clinical isolates of non-pigmented rapidly growing mycobacteria.
Esteban J; Martín-de-Hijas NZ; Ortiz A; Kinnari TJ; Bodas Sánchez A; Gadea I; Fernández-Roblas R
Int J Antimicrob Agents; 2009 Nov; 34(5):454-6. PubMed ID: 19665358
[TBL] [Abstract][Full Text] [Related]
30. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes.
Sungkanuparph S; Sathapatayavongs B; Pracharktam R
J Med Assoc Thai; 2003 Aug; 86(8):772-80. PubMed ID: 12948277
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic resistance in
Jayasingam SD; Zin T; Ngeow YF
Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
[TBL] [Abstract][Full Text] [Related]
32. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.
Kumar C; Shrivastava K; Singh A; Chauhan V; Varma-Basil M
Int J Mycobacteriol; 2021; 10(3):293-300. PubMed ID: 34494569
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
[TBL] [Abstract][Full Text] [Related]
34. In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.
Bennie CJ; To JL; Martin PA; Govendir M
Aust Vet J; 2015; 93(1-2):40-5. PubMed ID: 25622709
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Petrini B
APMIS; 2006 May; 114(5):319-28. PubMed ID: 16725007
[TBL] [Abstract][Full Text] [Related]
36. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility pattern of rapidly growing mycobacteria.
Gayathri R; Therese KL; Deepa P; Mangai S; Madhavan HN
J Postgrad Med; 2010; 56(2):76-8. PubMed ID: 20622384
[TBL] [Abstract][Full Text] [Related]
38. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.
Brown-Elliott BA; Hanson K; Vasireddy S; Iakhiaeva E; Nash KA; Vasireddy R; Parodi N; Smith T; Gee M; Strong A; Barker A; Cohen S; Muir H; Slechta ES; Wallace RJ
J Clin Microbiol; 2015 Mar; 53(3):875-8. PubMed ID: 25568437
[TBL] [Abstract][Full Text] [Related]
39. Comparison of methods for Identification of Mycobacterium abscessus and M. chelonae isolates.
Yakrus MA; Hernandez SM; Floyd MM; Sikes D; Butler WR; Metchock B
J Clin Microbiol; 2001 Nov; 39(11):4103-10. PubMed ID: 11682537
[TBL] [Abstract][Full Text] [Related]
40. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
